Meet Kevin, Your Case Manager

Alnylam Assist™ provides a dedicated Case Manager to guide and support each patient throughout the 
treatment journey with one-on-one interaction. 

Learn more about Kevin by watching the video below and see how a Case Manager can support you.

Meet Your Case Manager

Kevin At-A-Glance

Case Manager Kevin

My Experience

As a child, I was always the one who would have to translate for my grandmother at the pharmacy, doctor’s visits, etc. I realized that helping others is what I wanted to do.

My Inspiration

Patients with rare diseases are already going through so much. I wanted to be a point of contact for patients to make their lives easier as best as I can. Alnylam has a true passion for helping patients.

Why I Love What I Do

Some patients do not have anybody who can help them, and being able to help them with access-related questions will make their lives easier. Being able to be the person who helps someone get access to treatment is a rewarding feeling.

My Superpower

I can understand what dogs are thinking.

Favorite Things

I like to travel and explore. I love trying different foods and seeing new things.

Because I know about the different diseases, I have an understanding of what the patient is going through.

 

Kevin, Case Manager

Alnylam Assist® get started icon

See How to Get Started

Once you and your doctor decide to begin treatment with OXLUMO, we'll work with your healthcare team to start the process.

How to Get Started
Alnylam Assist® Case Manager Kevin

Call Kevin

1-833-256-2748

Monday - Friday,
8am - 6pm ET

Alylam Separator Triangles

IMPORTANT SAFETY INFORMATION

The most common side effect of OXLUMO® (lumasiran) is injection site reaction (redness, pain, itching, and swelling at the site of injection). These are not all the possible side effects of OXLUMO. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

OXLUMO has not been studied in pregnant or breastfeeding women. Talk to your doctor about the risk of taking OXLUMO if you are pregnant, plan to become pregnant, are breastfeeding, or plan to breastfeed.

WHAT IS OXLUMO?

OXLUMO is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine in children and adults.

For additional information about OXLUMO, please see the full Prescribing Information.